US Stock MarketDetailed Quotes

Inspire Medical Systems (INSP)

Watchlist
  • 57.590
  • +1.140+2.02%
Close Apr 17 16:00 ET
  • 57.548
  • -0.042-0.07%
Post 20:01 ET
1.66BMarket Cap11.78P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inspire Medical Systems (INSP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
13.60%911.98M
12.25%269.08M
10.49%224.5M
10.82%217.09M
22.75%201.32M
28.49%802.8M
24.52%239.72M
32.54%203.19M
29.65%195.89M
28.24%164.01M
Operating revenue
13.60%911.98M
12.25%269.08M
10.49%224.5M
10.82%217.09M
22.75%201.32M
28.49%802.8M
24.52%239.72M
32.54%203.19M
29.65%195.89M
28.24%164.01M
Cost of revenue
8.33%133.23M
0.23%36.07M
-1.93%31.77M
16.18%34.67M
24.04%30.71M
27.35%122.99M
28.28%35.99M
32.88%32.4M
23.05%29.84M
24.48%24.76M
Gross profit
14.55%778.76M
14.37%233.01M
12.84%192.73M
9.86%182.41M
22.52%170.61M
28.70%679.82M
23.88%203.73M
32.48%170.79M
30.91%166.04M
28.93%139.25M
Operating expense
13.06%727.8M
8.76%186.9M
17.01%183.08M
15.40%185.73M
11.41%172.09M
13.24%643.74M
10.76%171.85M
9.89%156.48M
12.20%160.94M
21.15%154.47M
Selling and administrative expenses
17.94%624.64M
14.45%161.95M
21.84%158.87M
20.77%159.52M
14.86%144.29M
17.18%529.61M
14.02%141.51M
15.14%130.39M
17.28%132.08M
23.17%125.62M
Research and development costs
-9.61%103.17M
-17.78%24.94M
-7.18%24.21M
-9.18%26.21M
-3.63%27.8M
-2.07%114.13M
-2.31%30.34M
-10.50%26.08M
-6.37%28.86M
13.05%28.85M
Operating profit
41.21%50.95M
44.62%46.11M
-32.64%9.64M
-165.03%-3.32M
90.24%-1.49M
189.60%36.08M
242.95%31.88M
206.29%14.32M
130.72%5.1M
21.95%-15.22M
Net non-operating interest income expense
-25.09%17.4M
-29.87%3.88M
-32.55%3.97M
-23.80%4.48M
-14.47%5.07M
12.96%23.23M
-5.79%5.53M
7.19%5.89M
19.50%5.88M
38.61%5.92M
Non-operating interest income
-24.57%17.54M
-27.95%4M
-32.36%3.98M
-23.73%4.49M
-14.47%5.07M
13.07%23.25M
-5.42%5.55M
7.19%5.89M
19.50%5.88M
38.61%5.92M
Non-operating interest expense
522.73%137K
454.55%122K
--11K
--4K
----
--22K
--22K
--0
--0
----
Other net income (expense)
-210.64%-2.66M
142.42%330K
-155.93%-66K
-2,491.11%-3.5M
1,063.33%578K
-338.46%-855K
-1,165.75%-778K
152.68%118K
-121.31%-135K
-452.94%-60K
Other non- operating income (expenses)
-210.64%-2.66M
142.42%330K
-155.93%-66K
-2,491.11%-3.5M
1,063.33%578K
-338.46%-855K
-1,165.75%-778K
152.68%118K
-121.31%-135K
-452.94%-60K
Income before tax
12.39%65.7M
37.35%50.32M
-33.33%13.55M
-121.50%-2.33M
144.46%4.16M
393.65%58.45M
140.39%36.64M
347.88%20.33M
192.40%10.85M
38.49%-9.36M
Income tax
-1,712.56%-79.73M
-6,174.43%-85.77M
97.87%3.62M
19.66%1.26M
79.54%1.17M
296.47%4.94M
196.02%1.41M
437.94%1.83M
392.06%1.05M
200.93%650K
Net income
171.77%145.42M
286.36%136.09M
-46.30%9.93M
-136.68%-3.59M
129.91%2.99M
352.96%53.51M
138.60%35.22M
316.59%18.5M
181.94%9.79M
35.13%-10.01M
Net income continuous Operations
171.77%145.42M
286.36%136.09M
-46.30%9.93M
-136.68%-3.59M
129.91%2.99M
352.96%53.51M
138.60%35.22M
316.59%18.5M
181.94%9.79M
35.13%-10.01M
Minority interest income
Net income attributable to the parent company
171.77%145.42M
286.36%136.09M
-46.30%9.93M
-136.68%-3.59M
129.91%2.99M
352.96%53.51M
138.60%35.22M
316.59%18.5M
181.94%9.79M
35.13%-10.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
171.77%145.42M
286.36%136.09M
-46.30%9.93M
-136.68%-3.59M
129.91%2.99M
352.96%53.51M
138.60%35.22M
316.59%18.5M
181.94%9.79M
35.13%-10.01M
Basic earnings per share
175.00%4.95
298.31%4.7
-45.16%0.34
-136.36%-0.12
129.41%0.1
350.00%1.8
136.00%1.18
313.79%0.62
180.49%0.33
35.85%-0.34
Diluted earnings per share
179.43%4.89
305.22%4.66
-43.33%0.34
-137.50%-0.12
129.41%0.1
343.06%1.75
134.69%1.15
306.90%0.6
178.05%0.32
35.85%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 13.60%911.98M12.25%269.08M10.49%224.5M10.82%217.09M22.75%201.32M28.49%802.8M24.52%239.72M32.54%203.19M29.65%195.89M28.24%164.01M
Operating revenue 13.60%911.98M12.25%269.08M10.49%224.5M10.82%217.09M22.75%201.32M28.49%802.8M24.52%239.72M32.54%203.19M29.65%195.89M28.24%164.01M
Cost of revenue 8.33%133.23M0.23%36.07M-1.93%31.77M16.18%34.67M24.04%30.71M27.35%122.99M28.28%35.99M32.88%32.4M23.05%29.84M24.48%24.76M
Gross profit 14.55%778.76M14.37%233.01M12.84%192.73M9.86%182.41M22.52%170.61M28.70%679.82M23.88%203.73M32.48%170.79M30.91%166.04M28.93%139.25M
Operating expense 13.06%727.8M8.76%186.9M17.01%183.08M15.40%185.73M11.41%172.09M13.24%643.74M10.76%171.85M9.89%156.48M12.20%160.94M21.15%154.47M
Selling and administrative expenses 17.94%624.64M14.45%161.95M21.84%158.87M20.77%159.52M14.86%144.29M17.18%529.61M14.02%141.51M15.14%130.39M17.28%132.08M23.17%125.62M
Research and development costs -9.61%103.17M-17.78%24.94M-7.18%24.21M-9.18%26.21M-3.63%27.8M-2.07%114.13M-2.31%30.34M-10.50%26.08M-6.37%28.86M13.05%28.85M
Operating profit 41.21%50.95M44.62%46.11M-32.64%9.64M-165.03%-3.32M90.24%-1.49M189.60%36.08M242.95%31.88M206.29%14.32M130.72%5.1M21.95%-15.22M
Net non-operating interest income expense -25.09%17.4M-29.87%3.88M-32.55%3.97M-23.80%4.48M-14.47%5.07M12.96%23.23M-5.79%5.53M7.19%5.89M19.50%5.88M38.61%5.92M
Non-operating interest income -24.57%17.54M-27.95%4M-32.36%3.98M-23.73%4.49M-14.47%5.07M13.07%23.25M-5.42%5.55M7.19%5.89M19.50%5.88M38.61%5.92M
Non-operating interest expense 522.73%137K454.55%122K--11K--4K------22K--22K--0--0----
Other net income (expense) -210.64%-2.66M142.42%330K-155.93%-66K-2,491.11%-3.5M1,063.33%578K-338.46%-855K-1,165.75%-778K152.68%118K-121.31%-135K-452.94%-60K
Other non- operating income (expenses) -210.64%-2.66M142.42%330K-155.93%-66K-2,491.11%-3.5M1,063.33%578K-338.46%-855K-1,165.75%-778K152.68%118K-121.31%-135K-452.94%-60K
Income before tax 12.39%65.7M37.35%50.32M-33.33%13.55M-121.50%-2.33M144.46%4.16M393.65%58.45M140.39%36.64M347.88%20.33M192.40%10.85M38.49%-9.36M
Income tax -1,712.56%-79.73M-6,174.43%-85.77M97.87%3.62M19.66%1.26M79.54%1.17M296.47%4.94M196.02%1.41M437.94%1.83M392.06%1.05M200.93%650K
Net income 171.77%145.42M286.36%136.09M-46.30%9.93M-136.68%-3.59M129.91%2.99M352.96%53.51M138.60%35.22M316.59%18.5M181.94%9.79M35.13%-10.01M
Net income continuous Operations 171.77%145.42M286.36%136.09M-46.30%9.93M-136.68%-3.59M129.91%2.99M352.96%53.51M138.60%35.22M316.59%18.5M181.94%9.79M35.13%-10.01M
Minority interest income
Net income attributable to the parent company 171.77%145.42M286.36%136.09M-46.30%9.93M-136.68%-3.59M129.91%2.99M352.96%53.51M138.60%35.22M316.59%18.5M181.94%9.79M35.13%-10.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 171.77%145.42M286.36%136.09M-46.30%9.93M-136.68%-3.59M129.91%2.99M352.96%53.51M138.60%35.22M316.59%18.5M181.94%9.79M35.13%-10.01M
Basic earnings per share 175.00%4.95298.31%4.7-45.16%0.34-136.36%-0.12129.41%0.1350.00%1.8136.00%1.18313.79%0.62180.49%0.3335.85%-0.34
Diluted earnings per share 179.43%4.89305.22%4.66-43.33%0.34-137.50%-0.12129.41%0.1343.06%1.75134.69%1.15306.90%0.6178.05%0.3235.85%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -